Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.

Szarek M, Bhatt DL, Miller M, Brinton EA, Jacobson TA, Tardif JC, Ballantyne CM, Mason RP, Ketchum SB, Lira Pineda A, Doyle RT Jr, Steg PG, REDUCE-IT Investigators

Open source

DOI
10.1016/j.jacc.2024.02.016
Published
2024 Apr 23
Container
Journal of the American College of Cardiology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacc.2024.02.016,
  title = {Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.},
  author = {Szarek M and Bhatt DL and Miller M and Brinton EA and Jacobson TA and Tardif JC and Ballantyne CM and Mason RP and Ketchum SB and Lira Pineda A and Doyle RT Jr and Steg PG and REDUCE-IT Investigators},
  year = {2024},
  journal = {Journal of the American College of Cardiology},
  doi = {10.1016/j.jacc.2024.02.016},
  url = {https://doi.org/10.1016/j.jacc.2024.02.016}
}

RIS

TY  - JOUR
TI  - Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.
AU  - Szarek M
AU  - Bhatt DL
AU  - Miller M
AU  - Brinton EA
AU  - Jacobson TA
AU  - Tardif JC
AU  - Ballantyne CM
AU  - Mason RP
AU  - Ketchum SB
AU  - Lira Pineda A
AU  - Doyle RT Jr
AU  - Steg PG
AU  - REDUCE-IT Investigators
PY  - 2024
JO  - Journal of the American College of Cardiology
DO  - 10.1016/j.jacc.2024.02.016
UR  - https://doi.org/10.1016/j.jacc.2024.02.016
ER  - 

APA

M, S., DL, B., M, M., EA, B., TA, J., JC, T., CM, B., RP, M., SB, K., A, L. P., Jr, D. R., PG, S., & Investigators, R. (2024). Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.02.016

Source records